Human Adoptive Transfer Core

$250,367P01FY2010CANIH

University Of Minnesota, Minneapolis MN

Investigators

Linked publications & trials

Paper 39622857 Paper 39545924 Paper 39264847 Paper 39008818 Paper 38916965 Paper 38418892 Paper 38160267 Paper 38044670 Paper 38018486 Paper 38000657 Paper 37898374 Paper 37706330 Paper 37467318 Paper 37337669 Paper 36521930 Paper 36327161 Paper 36162918 Paper 36099049 Paper 35967386 Paper 35955545 Paper 35917442 Paper 35917188 Paper 35821089 Paper 35727627 Paper 35581350 Paper 35563479 Paper 35503257 Paper 35493508 Paper 35443187 Paper 35414042 Paper 35369863 Paper 35272066 Paper 35259245 Paper 35194829 Paper 35176502 Paper 35077450 Paper 35021064 Paper 35015309 Paper 34986233 Paper 34797911 Paper 34758311 Paper 34737067 Paper 34712243 Paper 34707616 Paper 34707089 Paper 34668635 Paper 34653350 Paper 34637399 Paper 34634499 Paper 34631716 Paper 34619767 Paper 34614413 Paper 34614174 Paper 34581773 Paper 34575843 Paper 34570880 Paper 34551876 Paper 34525347 Paper 34496010 Paper 34493487 Paper 34491408 Paper 34461630 Paper 34439149 Paper 34436524 Paper 34398302 Paper 34367174 Paper 34327614 Paper 34312498 Paper 34304802 Paper 34298778 Paper 34291733 Paper 34174441 Paper 34151513 Paper 34117109 Paper 34101618 Paper 34044184 Paper 33980470 Paper 33893050 Paper 33855972 Paper 33836870 Paper 33785364 Paper 33781543 Paper 33753457 Paper 33718897 Paper 33712472 Paper 33673107 Paper 33666654 Paper 33599743 Paper 33560398 Paper 33449816 Paper 33441980 Paper 33441422 Paper 33428454 Paper 33421294 Paper 33420387 Paper 33239390 Paper 33238133 Paper 33222185 Paper 33178206 Paper 33168306

Abstract

The aim of this core is to use a xenotransplantation murine model to provide in vivo readouts for experiments proposed in this program project. Specifically, this model will be used for the following purposes: 1. To optimize proliferation and function of T regulatory cells (Treg) for suppression of alloreactive responses. 2. To perform studies testing the hypothesis that human thymocyte progenitor cells (Tprog) will accelerate human thymopoiesis and peripheral blood T cell responses in immunodeficient mice. 3. To optimize proliferation and function of natural killer (NK) cells for leukemia therapy. These data will in turn inform the design of future clinical trials. The core leader will provide valuable knowledge of the stem cell biology, gene manipulations, murine models, and clinical hematopoietic cell transplantation, all relevant to this application. Core D is unique in its capability to allow two of the three Principal Investigators (who do not have access to preclinical murine models;Project 1 and 3) with a critical shared resource to enhance their scientific program.

View original record on NIH RePORTER →